Medical Device News Magazine

Expert Data Scientist David Lamitina, PhD, Joins Perspecta

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Perspecta announced David Lamitina, Ph.D., has been added to its growing product team. Lamitina will join the company as a new Senior Data Scientist, with over 15 years of experience as a strategic technology leader.

Lamitina received his Ph.D. from the University of Nevada, Reno in Counseling and Educational Psychology. Most of his impressive career path focused around building longitudinal data systems, measuring learning, and modeling growth. From working in both large and small companies, both insider and in service of public education and healthcare, Lamitina has a rich background of experiences that help him appreciate the similarities and differences in how actors want to make use of data.

“There are two critical opportunities that drew me to Perspecta, which I believe are key to incorporating actionable Machine Learning into everyday business processes,” Lamitina says. “We have a large and ever-growing collection of provider data that few, if any, organization possesses and we have a long history of taking raw, unverified data and transforming it for accuracy and meaningful application.”

Jeff Wen, VP of Product Management, is excited about the level of knowledge and expertise that Lamitina brings to Perspecta.

“David has proven success in delivering data-driven applications and managing large-scale programs,” Wen says. “David will play a major role in leading Perspecta’s proprietary data-cleansing process via machine learning and solidifying our data analytics strategy, which will positively impact the dozens of Perspecta customers who already benefit from our data-cleansing solutions.”

Dr. Lamitina will further advance Perspecta’s product roadmap by designing data-driven solutions, developing meaningful products, delivering on customer-centric projects, and presenting data in an intuitive, meaningful way for better decision-making and user experience.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”